RESEARCH - Novel diagnosis of Lyme disease: potential for CAM intervention

[Guest guest]

eCAM Advance Access originally published online on October 15, 2007

eCAM 2009 6(3):283-295; doi:10.1093/ecam/nem138

Novel Diagnosis of Lyme Disease: Potential for CAM Intervention

Aristo Vojdani1, Hebroni2, Yaniv Raphael3, Erde4 and

Bernard Raxlen5

1Immunosciences Laboratory, Inc., Beverly Hills, CA 90211, 2Department

of Psychobiology, University of California, 3Department of Biology,

University of Southern California, 4Department of Biochemistry,

University of California and 5Raxlen Clinic, New York, NY 10024, USA

Abstract

Lyme disease (LD) is the most common tick-borne disease in the

northern hemisphere, producing a wide range of disabling effects on

multiple human targets, including the skin, the nervous system, the

joints and the heart. Insufficient clinical diagnostic methods, the

necessity for prompt antibiotic treatment along with the pervasive

nature of infection impel the development and establishment of new

clinical diagnostic tools with increased accuracy, sensitivity and

specificity. The goal of this article is 4-fold: (i) to detail LD

infection and pathology, (ii) to review prevalent diagnostic methods,

emphasizing inherent problems, (iii) to introduce the usage of in vivo

induced antigen technology (IVIAT) in clinical diagnostics and (iv) to

underscore the relevance of a novel comprehensive LD diagnostic

approach to practitioners of Complementary and Alternative Medicine

(CAM). Utilization of this analytical method will increase the

accuracy of the diagnostic process and abridge the time to treatment,

with antibiotics, herbal medicines and nutritional supplements,

resulting in improved quality of care and disease prognosis.

*********************************************

Read the full article here:

http://ecam.oxfordjournals.org/cgi/content/full/6/3/283

Not an MD